Mobix Labs annual cash and equivalents
2021
2022
2022
2023
2024
2025
Mobix Labs Cash & Equivalents Growth & History (MOBX)
Mobix Labs's cash and equivalents was $3.3M for fiscal 2025.
View full Mobix Labs company overviewMobix Labs annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $3.3M | $3.0M | +1130.45% |
| 2024 | 2024-09-30 | $266,000 | $258,475 | +3434.88% |
| 2023 | 2023-09-30 | $7,525 | −$170,475 | −95.77% |
| 2022 | 2022-12-31 | $175,788 | −$64,918 | −26.97% |
| 2022 | 2022-09-30 | $178,000 | — | — |
| 2021 | 2021-12-31 | $240,706 | — | — |
Mobix Labs quarterly cash and equivalents
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $2.1M | $1.9M | +792.50% |
| Q2 2026 | 2026-03-31 | $2.6M | $1.8M | +228.17% |
| Q1 2026 | 2025-12-31 | $268,000 | −$137,000 | −33.83% |
| Q4 2025 | 2025-09-30 | $3.3M | $3.0M | +1130.45% |
| Q3 2025 | 2025-06-30 | $240,000 | $35,000 | +17.07% |
| Q2 2025 | 2025-03-31 | $781,000 | −$2.2M | −73.91% |
| Q1 2025 | 2024-12-31 | $405,000 | −$14.4M | −97.26% |
| Q4 2024 | 2024-09-30 | $266,000 | $258,475 | +3434.88% |
| Q3 2024 | 2024-06-30 | $205,000 | $165,120 | +414.04% |
| Q2 2024 | 2024-03-31 | $3.0M | $2.9M | +2749.44% |
| Q1 2024 | 2023-12-31 | $14.8M | $14.6M | +8316.96% |
| Q4 2023 | 2023-09-30 | $7,525 | −$72,684 | −90.62% |
| Q2 2023 | 2023-06-30 | $39,880 | −$91,688 | −69.69% |
| Q1 2023 | 2023-03-31 | $105,038 | −$14,084 | −11.82% |
| Q4 2022 | 2022-12-31 | $175,788 | −$64,918 | −26.97% |
| Q3 2022 | 2022-09-30 | $80,209 | −$249,147 | −75.65% |
| Q2 2022 | 2022-06-30 | $131,568 | — | — |
| Q1 2022 | 2022-03-31 | $119,122 | — | — |
| Q4 2021 | 2021-12-31 | $240,706 | — | — |
| Q3 2021 | 2021-09-30 | $329,356 | — | — |
Mobix Labs cash and equivalents trends
Between the periods ended 2021-12-31 and 2025-09-30, Mobix Labs's cash and equivalents increased from $240,706 to $3.3M, a change of $3.0M. The latest reported quarter, Q3 2026, shows $2.1M.
About the metric
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Calculation and source
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mobix Labs source filings ↗